Tuzun, E. Et Al. 2022. Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios. 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , (Amsterdam, Netherlands), 778.

Tuzun, E., Turkoglu, R., Oezguen, N., Yilmaz, V., Akbayir, E., Horvath, T. D., ... Haidacher, S. J.(2022). Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios . 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (pp.778). Amsterdam, Netherlands

Tuzun, Erdem Et Al. "Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios," 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 2022

Tuzun, Erdem Et Al. "Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, pp.778, 2022

Tuzun, E. Et Al. (2022) . "Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, p.778.

@conferencepaper{conferencepaper, author={Erdem TÜZÜN Et Al. }, title={Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios}, congress name={38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis}, city={Amsterdam}, country={Netherlands}, year={2022}, pages={778} }